Optimizing the synergy between stereotactic radiosurgery and immunotherapy for brain metastases.

Yoo, Kelly H; Park, David J; Choi, John H; Marianayagam, Neelan J; Lim, Michael; Meola, Antonio; Chang, Steven D

Yoo, Kelly H; Park, David J; Choi, John H; Marianayagam, Neelan J; Lim, Michael; Meola, Antonio; Chang, Steven D.

Afiliación

Yoo KH; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, United States.
Park DJ; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, United States.
Choi JH; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, United States.
Marianayagam NJ; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, United States.
Lim M; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, United States.
Meola A; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, United States.
Chang SD; Department of Neurosurgery, Stanford University School of Medicine, Stanford, CA, United States.

Front Oncol ; 13: 1223599, 2023.

Article en En | MEDLINE | ID: mdl-37637032

Palabras clave

brain metastasis; combination therapy; immune checkpoint inhibitor; immunotherapy; stereotactic radiosurgery

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Front Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google